Previous research pointed out that coadministration with curcumin and cisplatin on cancer cells increased cytotoxicity to cisplatin, and was mediated by down-regulation of the expression levels of TP and ERCC1 and by inactivation of ERK1/2 [12]. The gene discussed is ERCC1; the disease is cancer.